Paper36005182
The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.
Wilkinson AN and 5 others. Curr Oncol, 2022. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59. Papers, record 36005182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36005182
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Canada | |
| Early Detection of Cancer | |
| Female | |
| Humans | |
| Mammography | |
| Mass Screening |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9709282 | Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. | J Natl Cancer Inst Monogr | 1997 | https://conductscience.org/library/papers/9709282 | PubMed |
| 2 | 9392331 | The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. | Cancer | 1997 | https://conductscience.org/library/papers/9392331 | PubMed |
| 3 | 29516087 | Race/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United States. | JAMA Surg | 2018 | https://conductscience.org/library/papers/29516087 | PubMed |
| 4 | 32390151 | Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. | Cancer | 2020 | https://conductscience.org/library/papers/32390151 | PubMed |
| 5 | 1423088 | Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. | CMAJ | 1992 | https://conductscience.org/library/papers/1423088 | PubMed |
| 6 | 21746751 | The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. | Eur J Public Health | 2012 | https://conductscience.org/library/papers/21746751 | PubMed |
| 7 | 9386870 | Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial. | Breast Cancer Res Treat | 1997 | https://conductscience.org/library/papers/9386870 | PubMed |
| 8 | 9110963 | Trends in breast cancer incidence and mortality. | Health Rep | 1996 | https://conductscience.org/library/papers/9110963 | PubMed |
| 9 | 15026792 | Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. | Br J Cancer | 2004 | https://conductscience.org/library/papers/15026792 | PubMed |
| 10 | 27480155 | Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27480155 | PubMed |
| 11 | 34523870 | The cancer survival index: Measuring progress in cancer survival to help evaluate cancer control efforts in Canada. | Health Rep | 2021 | https://conductscience.org/library/papers/34523870 | PubMed |
| 12 | 33770312 | Call to action: breast cancer screening recommendations for Black women. | Breast Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33770312 | PubMed |
| 13 | 23542028 | Point: The New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn. | J Am Coll Radiol | 2013 | https://conductscience.org/library/papers/23542028 | PubMed |
| 14 | 34812692 | The randomized trial of mammography screening that was not-A cautionary tale. | J Med Screen | 2022 | https://conductscience.org/library/papers/34812692 | PubMed |
| 15 | 32404449 | Breast Cancer Survivorship Tool: Facilitating breast cancer survivorship care for family physicians and patients. | Can Fam Physician | 2020 | https://conductscience.org/library/papers/32404449 | PubMed |
| 16 | 35735420 | Overdetection of Breast Cancer. | Curr Oncol | 2022 | https://conductscience.org/library/papers/35735420 | PubMed |
| 17 | 30411328 | The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. | Cancer | 2019 | https://conductscience.org/library/papers/30411328 | PubMed |
| 18 | 5107709 | Periodic breast cancer screening in reducing mortality from breast cancer. | JAMA | 1971 | https://conductscience.org/library/papers/5107709 | PubMed |
| 19 | 27066193 | Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. | Am Health Drug Benefits | 2016 | https://conductscience.org/library/papers/27066193 | PubMed |
| 20 | 23171096 | Effect of three decades of screening mammography on breast-cancer incidence. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23171096 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42166779 | Enhancing the OncoSim-Breast model using Canadian breast density information. | Health Rep | 2026 | https://conductscience.org/library/papers/42166779 | PubMed |
| 40445094 | Impact of Method of Detection of Breast Cancer on Clinical Outcomes in Individuals Aged 40 Years or Older. | Radiol Imaging Cancer | 2025 | https://conductscience.org/library/papers/40445094 | PubMed |
| 39900563 | 4D Dynamic contrast-enhanced breast CT: Phantom-based reconstruction parameter optimization for iodine quantification. | Med Phys | 2025 | https://conductscience.org/library/papers/39900563 | PubMed |
| 39702409 | Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline. | Syst Rev | 2024 | https://conductscience.org/library/papers/39702409 | PubMed |
| 39170933 | Insights into the Refusal of Free Screening Mammograms: Exploring Contributing Factors. | Breast Cancer (Dove Med Press) | 2024 | https://conductscience.org/library/papers/39170933 | PubMed |
| 38802897 | Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/38802897 | PubMed |
| 38668038 | The Canadian Breast Cancer Symposium 2023 Meeting Report. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38668038 | PubMed |
| 38017150 | Linking African ancestral substructure to prostate cancer health disparities. | Sci Rep | 2023 | https://conductscience.org/library/papers/38017150 | PubMed |
| 37754486 | Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37754486 | PubMed |
| 37540825 | Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37540825 | PubMed |
| 36975455 | Progress and Remaining Gaps in the Early Detection and Treatment of Breast Cancer. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36975455 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36005182
GET https://conductscience.org/api/papers/v1/36005182/references?page=2